Predictors of Treatment Response in Mood Disorders is the first text devoted solely to predicting responses to treatment in mood disorders. This concise, practical guide to clinical and biological factors affecting mood disorders will help clinicians and managed care administrators assign the correct somatic therapy -- the first time. In this day of increasingly scrutinized health care costs, it makes sense to examine all avenues of knowledge in predicting treatment response in mood disorders. Practical clinical examples from the chapter authors investigate questions such as, Which antidepressant should be used for atypical or bipolar depression? When should anticonvulsants be chosen over lithium? Does the DST or any blood test help in choosing medications? Chapters cover antidepressants (tricyclics, monoamine oxidase inhibitors, and SSRIs), mania treatments (lithium, carbamazepine, valproate, and neuroleptics), electroconvulsive therapy, and future treatment issues.
Sprache
Verlagsort
Verlagsgruppe
American Psychiatric Association Publishing
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Illustrationen
Maße
Höhe: 210 mm
Breite: 139 mm
Gewicht
ISBN-13
978-0-88048-494-7 (9780880484947)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Paul J. Goodnick, M.D., is Professor of Clinical Psychiatry and Director of the Mood Disorders Program at the University of Miami School of Medicine, Miami, Florida.
Tricyclic antidepressant medications. Monoamine oxidase inhibitors. Newer antidepressants. Lithium. Carbamazepine in bipolar disorder. Valproate. Neuroleptics and clozapine in mood disorders and schizophrenia. Electroconvulsive therapy: clinical and biological aspects. Comment and review. Index.